IMARC Group, a leading market research company, has recently released a report titled “Preterm Birth and PROM Testing Market Report by Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitrazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), and Others), Application (PROM, Preterm Labor, Chorioamnionitis), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2025-2033”. The study provides a detailed analysis of the industry, including the preterm birth and PROM testing market share, growth, trends, size and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global preterm birth and PROM testing market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033.

Request to Get the Sample Report: https://www.imarcgroup.com/preterm-birth-prom-testing-market/requestsample

Factors Affecting the Growth of the Preterm Birth and PROM Testing Industry:

Rising Awareness and Early Detection

The rising awareness of preterm birth and the need for early detection is changing the market for preterm birth and PROM testing. More healthcare professionals and expectant mothers understand the risks of preterm labor. This shift is increasing the demand for effective testing solutions. Educational campaigns and advances in prenatal care are fueling this growth. More screenings and diagnostic tests are happening now. Healthcare providers stress the need for timely interventions. Innovative testing technologies are emerging. They offer better accuracy and faster results. Increased awareness drives demand for PROM testing. This awareness also spurs research to improve maternal and fetal health.

Technological Advancements in Testing Methods

Technology is changing how we test for preterm birth and PROM. Non-invasive methods, like biomarker identification and advanced imaging, make diagnoses more accurate and reliable. Both healthcare providers and patients appreciate these advancements, as they reduce the need for risky invasive procedures. Additionally, artificial intelligence and machine learning are streamlining patient care and creating personalized treatment plans. As these technologies evolve, they will drive market growth by making testing more accessible and efficient. Ultimately, this will improve outcomes for mothers and infants.

Increasing Healthcare Expenditure and Policy Support

Rising healthcare costs and supportive policies are shaping the preterm birth and PROM testing market. Governments and organizations invest in better maternal and child care. This includes funding research and developing new tests. Policies also promote adopting innovative healthcare technologies. Such an environment helps new companies enter the market. Increased competition and innovation are expected. Healthcare providers and patients will have more testing options. Overall, demand for preterm birth and PROM testing will rise. Both public and private sectors drive this increase.

Speak to An Analyst: https://www.imarcgroup.com/request?type=reportid=8617flag=C

Preterm Birth and PROM Testing Market Report Segmentation:

Breakup by Test Type:

• Pelvic Exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitrazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others

The report found that ultrasound, the largest market segment, assists in preterm birth risk assessment by imaging the fetus, cervix, and amniotic fluid, with transvaginal ultrasound playing a crucial role in measuring cervical length.

Breakup by Application:

• PROM
• Preterm Labor
• Chorioamnionitis

Preterm labor, the largest market segment, accounts for the majority of market share due to its high prevalence and the increasing use of tests like cervical length measurement and fetal fibronectin testing to assess risk and facilitate timely interventions.

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Others

Hospitals, with their comprehensive healthcare services, medical expertise, and specialized departments, hold the biggest market share in preterm birth and PROM testing.

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America dominates the preterm birth and PROM testing market due to high awareness about testing options, increasing demand for early detection, high prevalence of preterm births, and the presence of innovative diagnostic technology providers.

Global Preterm Birth and PROM Testing Market Trends in 2025:

Trends in maternal health are changing, especially regarding preterm birth and PROM testing. By 2025, preventive healthcare will be a top priority. More systems will focus on early screening and assessing risks for preterm births. Advanced technologies like telemedicine and remote monitoring are key. They allow providers to monitor at-risk pregnancies closely and intervene promptly. Personalized medicine is also on the rise. It's leading to tailored testing solutions for individual patients. This proactive approach will significantly improve patient outcomes. Collaborations between healthcare providers and tech companies drive innovation. They ensure the market meets the needs of expectant mothers and their teams. By 2025, these trends will reshape the preterm birth and PROM testing market, making it more efficient and focused on patients.

Top Companies Operated in Preterm Birth and PROM Testing Industry:

• Clinical Innovations LLC (Laborie Medical Technologies Inc.)
• Cooper Surgical Inc. (The Cooper Companies Inc.)
• Hologic Inc.
• IQ Products
• NX Prenatal Inc.
• Qiagen N.V
• Sera Prognostics

Key Highlights of the Report:

• Market Performance (2019–2024)
• Market Outlook (2025–2033)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1–631–791–1145